On March 23, 2026, Imunon, Inc. filed a Form 8-K with the SEC, announcing the registration of an additional $7 million worth of shares of its common stock, par value $0.01 per share. This registration is part of the At the Market Offering Agreement established on May 25, 2022, and subsequently amended on May 15, 2024. The total amount registered under this agreement now stands at $17 million, which includes the previously registered $10 million. As of the filing date, the company has already sold approximately $4.8 million of shares through the sales agent, H.C. Wainwright & Co., LLC. This move is expected to enhance the company's liquidity position, allowing it to fund ongoing operations and potential growth initiatives. The filing also includes an opinion regarding the legality of the shares, which is standard practice in such offerings. Investors and analysts will be closely monitoring how this additional capital will be utilized and its potential impact on the company's financial health and stock performance in the coming months.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.